Novartis Q1 Earnings Call Highlights [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
fell 5% and core operating income dropped 14% as U.S. generic erosion and higher R&D drove a 4.1 percentage-point core margin decline. Management reaffirmed 2026 guidance — expecting low single-digit sales growth and a low single-digit decline in core operating income — calling it a “year of two halves” with H1 pressured by generics and a stronger H2; the company paid $9.1 billion in dividends and is executing an up to $10 billion buyback with about $6.1 billion remaining. Pipeline and launches: Rhapsido (remibrutinib) is off to a strong U.S. CSU launch with positive CIndU results, ianalumab received breakthrough designation in Sjögren's while a warm autoimmune hemolytic anemia study failed, and pelacarsen's HORIZON cardiovascular readout remains on track for H2. Interested in Novartis AG? Here are five stocks we like better. 3 ETFs to Avoid as Oil Shock Hits Markets Novartis (NYSE:NVS) executives said the company delivered “a strong start to the year” in the first quarter o
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Novartis finalizes US manufacturing and R&D expansion plan with seventh new facilityGlobeNewswire
- UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies [MSNBC.com]MSNBC.com
- UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies [CNBC]CNBC
- Novartis AG (NVS) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amidst Core Income ... [Yahoo! Finance]Yahoo! Finance
- Novartis Adds New Therapies As Shares Trade Below Analyst Value Targets [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 4/28/26 - Miss
NVS
Sec Filings
- 4/28/26 - Form 6-K
- 3/18/26 - Form 6-K
- 3/17/26 - Form FWP
- NVS's page on the SEC website